These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Brochet B, Deloire MS, Bonnet M, Salort-Campana E, Ouallet JC, Petry KG, Dousset V. Mult Scler; 2008 Nov; 14(9):1242-9. PubMed ID: 18653737 [Abstract] [Full Text] [Related]
23. Cognitive impairment and structural brain damage in benign multiple sclerosis. Rovaris M, Riccitelli G, Judica E, Possa F, Caputo D, Ghezzi A, Bertolotto A, Capra R, Falautano M, Mattioli F, Martinelli V, Comi G, Filippi M. Neurology; 2008 Nov 04; 71(19):1521-6. PubMed ID: 18815387 [Abstract] [Full Text] [Related]
26. The cognitive burden of multiple sclerosis in children. Banwell BL, Anderson PE. Neurology; 2005 Mar 08; 64(5):891-4. PubMed ID: 15753431 [Abstract] [Full Text] [Related]
27. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Zipoli V, Goretti B, Hakiki B, Siracusa G, Sorbi S, Portaccio E, Amato MP. Mult Scler; 2010 Jan 08; 16(1):62-7. PubMed ID: 19995837 [Abstract] [Full Text] [Related]
34. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Rovaris M, Judica E, Gallo A, Benedetti B, Sormani MP, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M. Brain; 2006 Oct 12; 129(Pt 10):2628-34. PubMed ID: 16921179 [Abstract] [Full Text] [Related]
35. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E, Lee JC, Nakamura K, Rudick RA. Ann Neurol; 2008 Sep 12; 64(3):255-65. PubMed ID: 18661561 [Abstract] [Full Text] [Related]
36. May there exist specific MRI findings predictive of dementia in multiple sclerosis patients? Patti F, Di Stefano M, De Pascalis D, Ciancio MR, De Bernardis E, Nicoletti F, Reggio A. Funct Neurol; 1995 Sep 12; 10(2):83-90. PubMed ID: 7557556 [Abstract] [Full Text] [Related]
37. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M. Mult Scler; 2009 Jul 12; 15(7):789-94. PubMed ID: 19465450 [Abstract] [Full Text] [Related]
38. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Arch Neurol; 2004 Feb 12; 61(2):226-30. PubMed ID: 14967771 [Abstract] [Full Text] [Related]
39. MRI correlates of cognitive dysfunction in multiple sclerosis patients. Rovaris M, Filippi M. J Neurovirol; 2000 May 12; 6 Suppl 2():S172-5. PubMed ID: 10871808 [Abstract] [Full Text] [Related]